Medigard Ltd (MGZ) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

BIG CHANGES! Try the new Market Index

For the best experience, create a free account.

Medigard Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $3.45 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

MGZ Statistics

19 January

2,328 / 2,256

ASX Size Rank

1yr Return

vs Sector (1yr)

-11.64%

vs ASX 200 (1yr)

+4.76%

$3.45 million

Market Cap

Share Issue

172.47 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

19 January

11.8

PE Ratio

EPS ($)

0.002

Earnings Yield

8.50%

NTA ($)

-

0.00%

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Medigard Limited (MGZ) is involved in medical technologies innovation and research and development, acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product, progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium MedicalProducts Co., Ltd on the Blood Collection Device and the Flash Back Needle.

Former Names
--

Medigard Ltd Logo

Corporate Details

Head Office: -
Managing Director: -
GICS Sub-Industry: Health Care Supplies
Date Listed: 5 Feb 2004
Registry: BoardRoom
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

26 Feb 2021 Report (Interim)
30 Aug 2021 Report (Prelim)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

MGZ is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Dr Ian Edward Dixon Executive Director Nov 2017
Mr Donald Julian Channer Non-Executive Director Oct 1999
Ms Patricia Mary Boero Chief Financial Officer, Alternate Director - Donald Channer, Company Secretary Mar 2006
Mr Craig Duncan Cameron Non-Executive Director Nov 2016
Dr Christopher Jan Bishop Non-Executive Director, Non-Executive Chairman Sep 2008

Director Transactions

About the Data

MGZ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
09/12/19 Ian Dixon Issued 14,608,569 $0.014 $204,519 Issue of securities.
09/12/19 Donald Channer Issued 7,142,857 $0.014 $100,000 Issue of securities.
09/12/19 Craig Cameron Issued 1,454,856 $0.014 $20,367 Issue of securities.
09/12/19 Christopher Bishop Issued 1,818,570 $0.014 $25,459 Issue of securities.
31/07/18 Ian Dixon Issued 80,000,000 $0.016 $1,280,000 Issue of options.
31/07/18 Ian Dixon Issued 1,428,571 $0.018 $25,000 Placement.
31/07/18 Donald Channer Issued 3,428,571 $0.018 $60,000 Placement.
31/07/18 Patricia Boero Issued 1,428,571 $0.018 $25,000 Placement.
31/07/18 Christopher Bishop Issued 3,714,285 $0.018 $65,000 Placement.
06/12/17 Patricia Boero Buy +3,500,000 $0.024 $85,050 Director remuneration.
06/12/17 Craig Cameron Buy +1,000,000 $0.024 $24,300 Director remuneration.
06/12/17 Christopher Bishop Buy +1,500,000 $0.024 $36,450 Director remuneration.
24/05/13 Peter Clark Sell -200,000 $0.035 ($7,000)
11/04/13 Peter Clark Sell -200,000 $0.019 ($3,800)
26/03/13 Peter Clark Sell -600,000 $0.015 ($9,000)

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 28 58 124 321 135 666

Top 20 Shareholders

About the Data

Name Shares Capital
Donald Julian Channer 30,546,263 22.58%
Robin J Bishop & Christopher J Bishop 5,214,285 3.85%
Sun Sea Pty Ltd 4,566,004 3.37%
Mr Warner Lamb & Mrs Aily Lamb 4,200,000 3.10%
Ganbaru Pty Ltd 3,767,004 2.78%
Allop Pty Ltd 3,607,143 2.67%
Woodwright Services Pty Ltd 3,500,000 2.59%
Mr Robert William Higham & Mrs Rhonda Catherine Higham 3,200,000 2.37%
Montezuma Pty Ltd 2,857,143 2.11%
Mr Richard Lutkajtis 2,127,734 1.57%
RHC Superfund Pty Ltd 1,553,575 1.15%
Mr Robert Krakowiak 1,500,000 1.11%
3DI Design Pty Ltd 1,500,000 1.11%
Helium Management Pty Ltd 1,428,571 1.06%
Joanne Hook 1,428,571 1.06%
Mrs Patricia Mary Boero & Mr John Anthony Boero 1,428,571 1.06%
Mr Matthew Simon Anthony Kelly 1,400,000 1.03%
Mr Gary Brian Stone & Mrs Janis Ann Stone 1,370,000 1.01%
Mr Philip Bickley Callard 1,295,684 0.96%
Mr Joel David Webb 1,200,000 0.89%
All other shareholders 42.57 %


The Top 20 Shareholders of MGZ hold 57.43% of shares on issue.

MGZ Share Price History

Date Close Change % Change Open High Low Volume Turnover

MGZ Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2020 $0.02 30 June
2019 $0.02 28 June
2018 $0.016 29 June
2017 $0.011 28 June
2016 $0.038 28 June
2015 $0.075 30 June
2014 $0.023 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Medical technologies innovation and research and development; acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product; progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium Medical Products Co., Ltd on the Blood Collection Device and the Flash Back Needle. The licence was terminated after the end of the financial year.

Incorporated: Medigard Limited was incorporated on 18 October 1999 in Queensland.

-

-


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.